Zobrazeno 1 - 10
of 1 515
pro vyhledávání: '"K. Geissler"'
Autor:
K. Geissler, Z. Koristek, T. Bernal del Castillo, J. Novák, G. Rodriguez Macias, S. K. Metzelder, A. Illes, A. Nagy, J. Mayer, M. Arnan, M.-M. Keating, J. Krauter, M. Lunghi, N. Stefano Fracchiolla, U. Platzbecker, V. Santini, Y. Sano, A. Oganesian, H. Keer, M. Lübbert
Publikováno v:
HemaSphere, Vol 6, Pp 472-473 (2022)
Externí odkaz:
https://doaj.org/article/2fd289b09b2543dd91e6344f36a40a45
Autor:
P. L. Zinzani, M. Özcan, K. Sapunarova, W. Jurczak, A. Hamed, K. Bouabdallah, G. Saydam, K. Geissler, Á. Szomor, M. Lazaroiu, A. Salar, A. Tempescul, M. Nalcaci, L. Gercheva, M. Egyed, P. Panayiotidis, L. Mongay Soler, A. Cao, C. Phelps, B. H Childs, M. J Matasar
Publikováno v:
HemaSphere, Vol 6, Pp 1028-1029 (2022)
Externí odkaz:
https://doaj.org/article/04696449ff50426f8b6ec43cb62e0dee
Autor:
A. DeZern, G. Marconi, D. Deeren, M. Diez Campelo, M. Lübbert, P. Krishnamurthy, Z. Nagy, G. Basak, A. Jonášová, E. Morozova, K. Geissler, Y. Ofran, H. Kelley, A. Volkert, K. Baker, Q. Kang-Fortner, G. Hodgson, C. Madigan, D. A. Roth, M. Kelly, P. Fenaux
Publikováno v:
HemaSphere, Vol 6, Pp 1800-1801 (2022)
Externí odkaz:
https://doaj.org/article/3ca739651e31453ea0e249099437f462
Autor:
Gunther Glehr, Paloma Riquelme, Katharina Kronenberg, Robert Lohmayer, Víctor J. López-Madrona, Michael Kapinsky, Hans J. Schlitt, Edward K. Geissler, Rainer Spang, Sebastian Haferkamp, James A. Hutchinson
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-21 (2024)
Abstract Immunological diseases are typically heterogeneous in clinical presentation, severity and response to therapy. Biomarkers of immune diseases often reflect this variability, especially compared to their regulated behaviour in health. This lea
Externí odkaz:
https://doaj.org/article/f1e2e526f7134e5596f23916f7bf3b45
Autor:
P. Kreiner, E. Eggenhofer, L. Schneider, C. Rejas, M. Goetz, N. Bogovic, S. M. Brunner, K. Evert, H. J. Schlitt, E. K. Geissler, H. Junger
Publikováno v:
Transplant International, Vol 37 (2024)
Biliary complications are still a major cause for morbidity and mortality after liver transplantation (LT). Ischemia/reperfusion injury (IRI) leads to disruption of the biliary epithelium. We introduce a novel model to study the effect of IRI on huma
Externí odkaz:
https://doaj.org/article/18e60a304db74bd69c9c31d6a0fcdeca
Autor:
Florian Bitterer, Paul Kupke, Akinbami Adenugba, Katja Evert, Gunther Glehr, Paloma Riquelme, Lena Scheibert, Giulia Preverin, Christina Böhm, Matthias Hornung, Hans J. Schlitt, Jürgen J. Wenzel, Edward K. Geissler, Niloufar Safinia, James A. Hutchinson, Jens M. Werner
Publikováno v:
EBioMedicine, Vol 104, Iss , Pp 105184- (2024)
Summary: Background: The increasing prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) incurs substantial morbidity, mortality and healthcare costs. Detection and clinical intervention at early stages of disease improves p
Externí odkaz:
https://doaj.org/article/8d3e4caeb8a74cc7af32f4f9594e9f84
Autor:
D. S. Wöhl, B. James, M. Götz, F. Brennfleck, I. Holub-Hayles, I. Mutzbauer, S. Baccar, S. M. Brunner, E. K. Geissler, H. J. Schlitt, on behalf of the EnGraft Trial Group
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-13 (2023)
Abstract Background Graft rejection and chronic CNI toxicity remain obstacles to organ transplant success. Current formulations of tacrolimus, such as Prograf® and Advagraf™, exhibit limitations in terms of pharmacokinetics and tolerability, relat
Externí odkaz:
https://doaj.org/article/4bba2207165c48b0bf1160865361fd36
Autor:
Paul Kupke, Johanna Brucker, Jochen M. Wettengel, Ulrike Protzer, Jürgen J. Wenzel, Hans J. Schlitt, Edward K. Geissler, Jens M. Werner
Publikováno v:
Viruses, Vol 16, Iss 5, p 741 (2024)
Hepatitis B virus (HBV) is a major driver of chronic hepatic inflammation, which regularly leads to liver cirrhosis or hepatocellular carcinoma. Immediate innate immune cell response is crucial for the rapid clearance of the infection. Here, natural
Externí odkaz:
https://doaj.org/article/08541a82fe7e490ab7eec775e3bc8885
Autor:
Jordi Yang Zhou, Dominik Eder, Florian Weber, Philipp Heumann, Katharina Kronenberg, Jens M. Werner, Edward K. Geissler, Hans J. Schlitt, James A. Hutchinson, Florian Bitterer
Publikováno v:
Frontiers in Transplantation, Vol 2 (2023)
BackgroundThe approval of Atezolizumab / Bevacizumab therapy (Atezo/Bev) in 2020 opened up a promising new treatment option for patients with end-stage hepatocellular carcinoma (HCC). However, liver transplant (LTx) patients with HCC are still denied
Externí odkaz:
https://doaj.org/article/f62aab5a93d84130a02b902ad9f3715e
Autor:
Edward K. Geissler, PhD, Günter Kirste, MD, Maureen O. Meade, MD, Jeremy R. Chapman, AC, MD, FRACP
Publikováno v:
Transplantation Direct, Vol 9, Iss 5, p e1481 (2023)
Externí odkaz:
https://doaj.org/article/89b1c5fb169d48c59ead48bb5d6f15ad